Biochemistry Analyzer Market Report 2025

This Biochemistry Analyzer market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The biochemistry analyzer market size has grown strongly in recent years. It will grow from $4.31 billion in 2024 to $4.62 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increased incidence of chronic diseases, growing healthcare infrastructure, rising research and development activities, high demand for diagnostic accuracy, an aging population, and government initiatives.

The biochemistry analyzer market size is expected to see strong growth in the next few years. It will grow to $6.01 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to the emergence of personalized medicine, expansion in emerging markets, advancements in analytical techniques, rising focus on preventive healthcare, integration of AI and machine learning, increased investment in research, and demand for cost-effective solutions. Major trends in the forecast period include technological integration, miniaturization and portability, enhanced automation, personalized diagnostics, integration with healthcare IT systems, increased use of molecular diagnostics, and a focus on sustainability.

The biochemistry analyzer market is expected to grow due to the rising incidence of cardiovascular disorders. Cardiovascular diseases encompass various conditions affecting the heart and blood vessels, including complications such as heart attack, stroke, and peripheral artery disease (PAD). The prevalence of these conditions is increasing due to factors such as an aging population, sedentary lifestyles, poor dietary habits, and high obesity rates. Biochemistry analyzers play a crucial role in diagnosing and managing cardiovascular disorders by providing accurate and timely measurements of key biomarkers. This helps healthcare professionals monitor patient health, assess risk factors, and customize treatment plans. For example, in January 2024, the American Heart Association reported that cardiovascular disease-related deaths in the US increased to 931,578 from 928,741 in 2023. Additionally, the age-adjusted death rate for cardiovascular diseases rose to 233.3 per 100,000 in 2024, a 4% increase from 224.4 per 100,000 in 2023. This rising incidence of cardiovascular disorders is fueling the growth of the biochemistry analyzer market.

Leading companies in the biochemistry analyzer market are focusing on developing advanced immunoassay analyzer platforms to improve diagnostic accuracy and reduce maintenance needs. These platforms use immunoassay techniques to measure specific biomarkers in biological samples, offering high accuracy and sensitivity for detecting various conditions, thus enhancing diagnostic efficiency and patient care. For instance, in May 2023, Beckman Coulter Inc., a US-based clinical diagnostics firm, introduced the DxI 9000 Access Immunoassay Analyzer. This state-of-the-art platform can perform up to 215 tests per hour per square meter and includes advanced features such as PrecisionVision Technology for real-time data accuracy, ZeroDaily Maintenance to minimize upkeep, and IntelliServe for proactive remote service and diagnostics. The DxI 9000 also supports rapid and precise heart failure diagnosis through its NT-proBNP assay and enhances assay sensitivity with the Lumi-Phos PRO Substrate, catering to the growing demand for speed, reliability, and precision in clinical laboratories.

In December 2023, Mindray Medical International Limited, a China-based medical device company that develops and manufactures medical equipment and accessories for both humans and animals, acquired DiaSys Diagnostic Systems GmbH for an undisclosed amount. This acquisition allows Mindray Medical International Limited to expand its in-vitro diagnostics portfolio, enhance its global supply chain capabilities, and strengthen its competitive position in the healthcare market. DiaSys Diagnostic Systems GmbH, a Germany-based manufacturer, specializes in providing innovative diagnostic solutions, including biochemistry analyzers.

Major companies operating in the biochemistry analyzer market are Roche Holding AG, Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Agilent Technologies, Mindray Bio-Medical Electronics Co. Ltd., Hologic Inc., Hitachi High-Technologies Corporation, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics, Horiba Medical Ltd, Randox Laboratories Ltd., NOVA Biomedical Corp., Tecom Group, Dirui Industries Co. Ltd., Transasia Biomedicals Ltd., ELITechGroup, Medison Pharma, NantHealth Inc., Awareness Technology Inc., Rayto Life and Analytical Sciences Co. Ltd., DPC (Diagnostic Products Corporation), Cypress Diagnostics Inc, Urit Medical Electronic Group, Adaltis Inc.

Europe was the largest region in the biochemistry analyzer market in 2024. The regions covered in the biochemistry analyzer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biochemistry analyzer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A biochemistry analyzer is a medical laboratory instrument designed to measure the concentration of various biochemical substances in biological samples. It performs tests to analyze enzymes, electrolytes, proteins, and other biochemical compounds by conducting chemical reactions and providing quick, accurate results.

The primary types of biochemistry analyzers are semi-automated and fully-automated. A semi-automated biochemistry analyzer is a device that requires some manual intervention for tasks such as sample preparation or reagent handling but automates the testing process. These analyzers come in different modalities, including bench-top and floor-standing models. They are used in various applications such as clinical diagnostics, bioreactor byproduct detection, and drug development. End users include hospitals, diagnostic centers, pharmaceutical companies, biotechnology firms, academic research institutes, and contract research organizations.

The biochemistry analyzer market research report is one of a series of new reports that provides biochemistry analyzer market statistics, including biochemistry analyzer industry global market size, regional shares, competitors with an biochemistry analyzer market share, detailed biochemistry analyzer market segments, market trends and opportunities, and any further data you may need to thrive in the biochemistry analyzer industry. This biochemistry analyzer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A biochemistry analyzer market consists of sales of reagent kits, control and calibration solutions, software for data management, and consumables to support the operation and performance of the analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.